-
Je něco špatně v tomto záznamu ?
The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrier
B. Vraníková, P. Svačinová, J. Marushka, J. Brokešová, O. Holas, JD. Tebbens, Z. Šklubalová
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- hořčík * MeSH
- oxid křemičitý * MeSH
- prášky, zásypy, pudry MeSH
- příprava léků MeSH
- rozpustnost MeSH
- tablety MeSH
- Publikační typ
- časopisecké články MeSH
Albeit the preparation of liquisolid systems represents an innovative approach to enhance the dissolution of poorly soluble drugs, their broader utilization is still limited mainly due to the problematic conversion of the liquid into freely flowing and readily compressible powder. Accordingly, the presented study aims to determine the optimal carrier/coating material ratio (R value) for formulations based on magnesium aluminometasilicate (NUS2) loaded with polyethylene glycol 400. Four commercially available colloidal silica were used as coating materials in nine different R values (range of 5 - 100). The obtained results suggested that the higher R value leads to the superior properties of powder mixtures, such as better flowability, as well as compacts with higher tensile strength and lower friability. Moreover, it was observed that the type of coating material impacts the properties of liquisolid systems due to the different arrangement of particles in the liquisolid mixture. To confirm the noted dependency of R value and coating material type, the one- and two-way ANOVA, linear regression and principal component analysis (PCA) techniques were performed. In addition, a comparison of results with the properties of loaded NUS2 itself revealed that LSS with sufficient properties may be prepared even without the coating material.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024912
- 003
- CZ-PrNML
- 005
- 20211026134302.0
- 007
- ta
- 008
- 211013s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejps.2021.105952 $2 doi
- 035 __
- $a (PubMed)34298140
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vraníková, Barbora $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: vranikovab@faf.cuni.cz
- 245 14
- $a The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrier / $c B. Vraníková, P. Svačinová, J. Marushka, J. Brokešová, O. Holas, JD. Tebbens, Z. Šklubalová
- 520 9_
- $a Albeit the preparation of liquisolid systems represents an innovative approach to enhance the dissolution of poorly soluble drugs, their broader utilization is still limited mainly due to the problematic conversion of the liquid into freely flowing and readily compressible powder. Accordingly, the presented study aims to determine the optimal carrier/coating material ratio (R value) for formulations based on magnesium aluminometasilicate (NUS2) loaded with polyethylene glycol 400. Four commercially available colloidal silica were used as coating materials in nine different R values (range of 5 - 100). The obtained results suggested that the higher R value leads to the superior properties of powder mixtures, such as better flowability, as well as compacts with higher tensile strength and lower friability. Moreover, it was observed that the type of coating material impacts the properties of liquisolid systems due to the different arrangement of particles in the liquisolid mixture. To confirm the noted dependency of R value and coating material type, the one- and two-way ANOVA, linear regression and principal component analysis (PCA) techniques were performed. In addition, a comparison of results with the properties of loaded NUS2 itself revealed that LSS with sufficient properties may be prepared even without the coating material.
- 650 _2
- $a příprava léků $7 D004339
- 650 12
- $a hořčík $7 D008274
- 650 _2
- $a prášky, zásypy, pudry $7 D011208
- 650 12
- $a oxid křemičitý $7 D012822
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a tablety $7 D013607
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Svačinová, Petra $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: SVACP3AA@faf.cuni.cz
- 700 1_
- $a Marushka, Julia $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic; Department of Biophysics and Physical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: marushki@faf.cuni.cz
- 700 1_
- $a Brokešová, Jana $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: brokesoj@faf.cuni.cz
- 700 1_
- $a Holas, Ondrej $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: HOLAO3AA@faf.cuni.cz
- 700 1_
- $a Tebbens, Jurjen Duintjer $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: jurjend@faf.cuni.cz
- 700 1_
- $a Šklubalová, Zdenka $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: sklubalova@faf.cuni.cz
- 773 0_
- $w MED00001639 $t European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 165, č. - (2021), s. 105952
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34298140 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026134308 $b ABA008
- 999 __
- $a ok $b bmc $g 1714109 $s 1145419
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 165 $c - $d 105952 $e 20210720 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
- LZP __
- $a Pubmed-20211013